Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 1 5Phase 3 4Phase NA 3Phase EARLY_PHASE1 3Phase 4 3Phase 1/2 2Phase 2/3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Head & Neck 4Gynecologic 3Breast 3Other 2Genitourinary 2Gastrointestinal 2Thoracic 1NET 1Endocrine 1CNS 1

Conditions

Breast Neoplasms 2Triple Negative Breast Neoplasms 1Obesity 1

Interventions

Letrozole 9Fluorodeoxyglucose F18 7pembrolizumab 6Magnetic Resonance Spectroscopy 6atezolizumab 5Blood Specimen Collection 5Trastuzumab 4Oncolytic Virotherapy 4Biopsy 4Bevacizumab 4palbociclib 3durvalumab 3Vitamin D 3Taxes 3Saline Solution 3Radiotherapy 3Metformin 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Albumin-Bound Paclitaxel 3pertuzumab 2olaparib 2bazedoxifene 2Vinorelbine 2Tamoxifen 2Sentinel Lymph Node Biopsy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Metformin × Breast × Clear all
NCT01980823 2023-08-30

Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer

Columbia University

Phase EARLY_PHASE1 Completed
23 enrolled
Breast

Breast Neoplasms

NCT05680662 2023-01-11

The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism

Ministry of Health, Saudi Arabia

Phase EARLY_PHASE1 Unknown
200 enrolled
Breast

Triple Negative Breast Neoplasms

NCT01793948 2018-03-30

Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer

Indiana University

Phase EARLY_PHASE1 Completed
24 enrolled
BreastOther

Breast Neoplasms, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡